Bayzed Health Group Inc (HKG:2609)
Hong Kong
· Delayed Price · Currency is HKD 3.300
+0.050 (1.54%)
Mar 10, 2026, 3:32 PM HKT
Bayzed Health Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -29.53 | -13.46 | -26.39 | -58.02 | -46.09 |
| Depreciation & Amortization | 86.01 | 85.04 | 84.69 | 73.4 | 49.57 |
| Other Amortization | 2.36 | 2.36 | 1.58 | 1.14 | 0.76 |
| Loss (Gain) From Sale of Assets | -0 | -0 | 0.18 | 0.04 | -0.33 |
| Stock-Based Compensation | - | - | - | 0.18 | - |
| Provision & Write-off of Bad Debts | 0.65 | 0.65 | 0.27 | 2.06 | 0.46 |
| Other Operating Activities | 49.2 | 21.15 | 28.82 | 8.21 | 1.2 |
| Change in Accounts Receivable | -86.42 | -86.42 | -26.27 | -33.08 | -29.39 |
| Change in Inventory | -3.1 | -3.1 | -3.76 | -7.34 | -13.19 |
| Change in Accounts Payable | 232.53 | 232.53 | 67.14 | 46.34 | 70.82 |
| Change in Unearned Revenue | -44.84 | -44.84 | -7.8 | 69.33 | 8.86 |
| Change in Other Net Operating Assets | -25.37 | -25.37 | 9.91 | 12.13 | -36.26 |
| Operating Cash Flow | 181.49 | 168.54 | 128.37 | 114.4 | 6.42 |
| Operating Cash Flow Growth | 45.73% | 31.29% | 12.22% | 1683.24% | - |
| Capital Expenditures | -41.8 | -43.87 | -45.37 | -29.44 | -49.06 |
| Cash Acquisitions | - | - | - | -149.36 | -23.8 |
| Sale (Purchase) of Intangibles | -2.63 | -2.58 | -8.44 | -6.91 | -4.92 |
| Other Investing Activities | 25.97 | 98.62 | -4.8 | -22.97 | -78.67 |
| Investing Cash Flow | -18.46 | 52.17 | -58.61 | -208.68 | -156.45 |
| Short-Term Debt Issued | - | - | - | 6.63 | - |
| Long-Term Debt Issued | - | 206.81 | 243.59 | 184.9 | 70.6 |
| Total Debt Issued | 249.94 | 206.81 | 243.59 | 191.53 | 70.6 |
| Short-Term Debt Repaid | - | -1.5 | -46.51 | -70.55 | -15.54 |
| Long-Term Debt Repaid | - | -369.85 | -237.93 | -91.65 | -174.37 |
| Total Debt Repaid | -394.37 | -371.35 | -284.44 | -162.21 | -189.91 |
| Net Debt Issued (Repaid) | -144.43 | -164.54 | -40.85 | 29.32 | -119.31 |
| Issuance of Common Stock | 516.73 | 3.6 | 130.87 | 71.11 | 395.12 |
| Other Financing Activities | -17.5 | -7.52 | -42.99 | -47.01 | -45.45 |
| Financing Cash Flow | 354.8 | -168.46 | 47.04 | 53.43 | 230.36 |
| Net Cash Flow | 517.82 | 52.25 | 116.8 | -40.86 | 80.32 |
| Free Cash Flow | 139.69 | 124.67 | 83 | 84.96 | -42.65 |
| Free Cash Flow Growth | 73.09% | 50.20% | -2.30% | - | - |
| Free Cash Flow Margin | 11.71% | 10.49% | 7.74% | 10.59% | -9.24% |
| Free Cash Flow Per Share | 0.11 | 0.10 | 0.07 | - | - |
| Cash Interest Paid | 20.42 | 21.5 | 26.66 | 23.62 | 20.95 |
| Cash Income Tax Paid | 22.82 | 27.3 | 20 | 8.98 | 8.55 |
| Levered Free Cash Flow | 56.48 | 89.76 | 9.34 | 134.19 | - |
| Unlevered Free Cash Flow | 69.24 | 103.19 | 26 | 148.95 | - |
| Change in Working Capital | 72.8 | 72.8 | 39.22 | 87.37 | 0.85 |
Source: S&P Capital IQ. Standard template. Financial Sources.